88 search results for “vaccine” in the Staff website
-
Gideon KerstenFaculty of Science
g.f.a.kersten@lacdr.leidenuniv.nl | +31 71 527 4570
-
Synthesis and immunological evaluation of Pel and Psl glycoconjugate vaccine candidates against Pseudomonas aeruginosa
PhD defence
-
Lipid nanoparticle technology for mRNA delivery: Bridging vaccine applications with fundamental insights into nano-bio interactions
PhD defence
-
Bram SlütterFaculty of Science
b.a.slutter@lacdr.leidenuniv.nl | +31 71 527 6208
-
New easy-to-use tuberculosis vaccine patch in development
Researchers from Leiden have developed a promising TB vaccine that users can self-administer via a special patch. This could be beneficial for countries with limited health services, says PhD candidate Malene Neustrup.
-
Aart Hendriks not ruling out compulsory vaccination
Now the number of people with COVID-19 is increasing and we are faced with stricter measures once again, the question arises whether compulsory vaccination could be allowed.
-
Animation: Why Leiden is the birthplace of the Janssen vaccine
If you'll soon be getting a COVID-19 vaccine, you might just get the Johnson & Johnson (Janssen) one. This vaccine was developed for the most part in Leiden – and this is no coincidence. Watch the animation below about the development of one of the vaccines in the fight against COVID-19.
-
How NeCEN helped develop the Johnson & Johnson Covid-19 vaccine
The Phase 3 clinical trial results of the promising Covid-19 vaccine of Johnson & Johnson are expected this month. The Dutch electron microscopy facility NeCEN helped develop the company’s vaccine, and they have now published their scientific findings in Nature Communications.
-
‘We couldn't really celebrate our vaccine being approved, but we were over the moon’
On 11 March, pharmaceutical company Janssen received approval to launch its corona vaccine on the European market. This made Janssen the fourth company to be given the green light by the European Medicines Agency. As Lead of the Janssen Campus in the Netherlands, Biology alumnus Bart van Zijll Langhout…
-
master student Linde Schoenmaker publishes review paper about COVID-19 vaccine stability
During her search for a subject for the literature study of the Bio-Pharmaceutical Sciences master programme, Linde Schoenmaker read a press release about the ultra-low storage temperatures of the COVID-19 vaccines. She wondered why these vaccines must be stored at such cold conditions. Her question…
-
Jeroen CodeeFaculty of Science
jcodee@chem.leidenuniv.nl | +31 71 527 5037
-
Travel advice
If you are going on a business trip to a destination that poses health risks, you can make an appointment with the specialised nurses of the University. They can give you advice and indicate whether you will require any vaccinations or malaria medication.
-
Maria YazdanbakhshFaculteit Geneeskunde
m.yazdanbakhsh@lumc.nl | +31 71 526 5067
-
Nanoparticles and Microfluidics for Future Tuberculosis Vaccines
PhD defence
-
Engineering of antigen saving dissolving Microneedles for intradermal vaccine delivery
PhD defence
-
Marjolein IsendoornFaculty of Science
m.m.e.isendoorn@lic.leidenuniv.nl | +31 71 527 3576
-
Business trips abroad
If you plan to make a business trip abroad? Ask your manager for permission in advance.
-
Liposome-based vaccines for immune modulation: from antigen selection to nanoparticle design
PhD defence
-
Leiden University honours Lex van der Eb with University Medal
Leiden University has awarded its prestigious University Medal to Emeritus Professor Lex van der Eb. As a pioneer in genetics and molecular biology, he received this honour for his services to science and his key role in the development of the Leiden Bio Science Park (LBSP).
-
Joke BouwstraFaculty of Science
bouwstra@lacdr.leidenuniv.nl | +31 71 527 2727
-
Jannik RouselFaculty of Science
j.rousel.2@umail.leidenuniv.nl | +31 71 527 2727
-
The most read stories of 2021 from Leiden University
Research into depression in children, Leiden alumni in the Dutch House of Representatives and an exceptional achievement by one of our students: what do this topics have in common? They are among our most read stories of 2021.
-
Leiden students develop highly contagious card game
Infecting each other with viruses and bacteria while protecting yourself with medicines and vaccinations. Sounds like a fun evening, right? Master students Life Science & Technology Rafael Jezior and Dennis de Beeld certainly think so. Together, they developed ImmunoWars: an exciting card game based…
-
Werken aan een effectiever malariavaccin
In het Leids Universitair Medisch Centrum wordt gewerkt aan de ontwikkeling van een nieuw malariavaccin dat effectiever is dan de huidige vaccins.
-
New statistical method brings together studies at an early stage
During the coronavirus pandemic, scientists were in a hurry to find drugs that would help fight the disease. To combine the research that was being carried out around the world, PhD candidate Judith ter Schure developed a new statistical method: ALL-IN meta-analysis. This helps determine sooner whether…
-
Our man in Jakarta keeps the institute running from Venlo
The COVID-19 pandemic forced many staff of Leiden institutes abroad to leave their posts in a hurry. How is the KITLV Jakarta team doing now? Director Marrik Bellen talks about the turbulent times for this Leiden institute and its staff. And can we learn anything from the Indonesian approach?
-
Vidi grant for seven researchers from Leiden University
From malaria parasites as a vaccine to how top-level bureaucrats reach their decisions: seven researchers from Leiden University have received a Vidi grant from the Dutch Research Council (NWO). This 800,000-euro grant will enable them to develop their own innovative line of research over the next five…
-
Leiden researchers join forces against tuberculosis
About one and a half million people worldwide die each year from tuberculosis. For thirty years, therapy with antibiotics has been the same, while it takes far too long and can lead to resistant pathogens. Leiden researchers from four institutes are now joining forces to develop more effective and efficient…
-
Six Leiden researchers receive ERC Starting Grant
Six researchers from Leiden University have received an ERC starting grant. This grant of on average 1.5m euros will enable the researchers to launch their own project, form their own research team and develop their best ideas.
-
Making the invisible visible with ‘click chemistry’
Sander van Kasteren (Professor of Molecular Immunology) makes the invisible visible. He will explain more in his inaugural lecture.
-
Catherine MergenFaculty of Science
c.mergen@lacdr.leidenuniv.nl | 071 5276038
-
GP in the Bible Belt: does God play a role in consultations?
Jaïr van Rhenen studied Medicine in Leiden and is now a GP in the largely religious Veenendaal. Before this, he worked as a tropical medicine doctor in Lesotho. ‘If you have the prospect of an afterlife, you often respond differently to illness.’
-
Hester Bijl: ‘On-campus teaching is a big step forward, so take care’
‘We’re going to see each other again on campus. We’re so pleased, but we do have to say safe.’ Rector Magnificus Hester Bijl is looking ahead to the new academic year, which begins on 6 September. No more 1.5m distancing, but we do have to take responsibility for other people’s safety.
-
University doctor
Leiden University is committed to creating a pleasant working environment for its staff. It may nevertheless happen that you find yourself unable to work due to a temporary or long-term illness or disability. The university doctors can help you reduce health risks and give you advice regarding your…
-
University doctor
Leiden University is committed to creating a pleasant working environment for its staff. It may nevertheless happen that you find yourself unable to work due to a temporary or long-term illness or disability. The university doctors can help you reduce health risks and give you advice regarding your…
-
LACDR PhD-Postdoc event - 12 October 2022
On October 12th, the LACDR PhD-Postdoc event will be organized in castle Oud Poelgeest.
-
PhD-Postdoc event 2022
Last October, we organized our annual PhD-Postdoc event at Kasteel Oud-Poelgeest. An important part of the program was a speed dating session with LACDR alumni.
-
Symposium: A Dutch Perspective on Mycobacterial Infections
On March 24, 2025, World TB Day, we (Annemarie Meijer (IBL), Matthias Barz (LACDR), and Simone Joosten (LUMC) hosted the symposium „A Dutch Perspective on Mycobacterial Infections“, which brought together the Dutch scientific community working on mycobacterial infections.
-
Thirteen NWO Open Competition XS grants for Leiden researchers
From medicines from snake venom to supercrops and the origin of words. Thirteen researchers from Leiden University will receive Open Competition XS grants from the Dutch Research Council (NWO).
-
Vidi grants for eight researchers from Leiden University
Eight scientists from Leiden University have been awarded a grant by the Dutch Research Council (NWO). With this Vidi funding, the researchers can set up an innovative line of research and further expand their own research group over the next five years.
-
‘Value to society has our full attention’
Rector Magnificus Hester Bijl can see dilemmas but above all opportunities in the search to increase the societal value of research in Leiden.
-
How bittersweet sugar chemistry targets pathogens
The challenge is considerable, but so is the satisfaction when it succeeds: creating complex sugar molecules that play a role in biology.
-
Major Leiden symposium on TB bacteria
More than 1.3 million people worldwide die of tuberculosis (TB) each year, making research on its prevention and control essential. Researchers from various disciplines in Leiden are studying TB. A symposium on 24 March will highlight different activities in the hope of boosting nationwide collabora…
-
Recent PhD defenses
Here we highlight the achievements of our latest PhD graduates, each of whom has made significant contributions to the advancement of the field of (bio)pharmaceutical sciences.
-
LACDR Spring symposium 2023
It was great to welcome so many people at the LACDR Spring symposium on the 4th of April 2023. The meeting started with an inspiring lecture of Dr. Mustafa Diken (Bioentech) on the evolution of mRNA vaccines. Afterwards, PhD speakers from LACDR, LIC and CHDR gave presentations on a wide range of pharma-related…
-
Discover the Oncode Accelerator research funds for cancer therapies
Research
-
BPS MSc course Design, Analysis, and Practical Use of Biologicals
BPS MSc student Guus Ruiter: This year I followed this new course called Design, Analysis, and Practical Use of Biologicals at the LUMC given by Rawi Ramautar and developed for both BPS MSc and Pharmacy students. During this course, there were many different speakers, in particular from biotech companies…
-
Prof Dr Joke Bouwstra receives the “ Dr Saal van Zwanenberg Ereprijs”
Prof Dr Joke Bouwstra will receive the “ Dr Saal van Zwanenberg Ereprijs” from the “Koninklijke Hollandse Maatschappij der Wetenschappen” on November 14 in Haarlem. Joke is awarded for her innovative contributions to the field of skin delivery science and technology. She shares the price with prof…
-
ERA4Health grants for Bram Slütter, Amanda Foks and Ilze Bot
Recently, Bram Slütter, Amanda Foks and Ilze Bot all individually obtained an ERA4Health research grant from the CARDINNOV 2023 program. In this program, which is co-funded by the EU and in the Netherlands by ZonMW, 17 consortia consisting of 3-5 European academic partners were selected for funding…
-
Veni grants for 18 Leiden researchers
Eighteen researchers from Leiden University have been awarded a Veni grant by the Dutch Research Council (NWO). This grant gives promising young researchers the opportunity to develop their ideas for a period of three years.